Pollutant Removal Efficiency of an Urban Stormwater Wetland in Lansing Township, Michigan von Campbell, E J, Wayland, K, Pelikan, K, Ditschman, E P, Lindemann, P E

Volltext

FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positi... von Bergh, Jonas, Jönsson, Per-Ebbe, Lidbrink, Elisabet Kerstin, Trudeau, Maureen, Eiermann, Wolfgang, Brattström, Daniel, Lindemann, Justin P O, Wiklund, Fredrik, Henriksson, Roger

Volltext

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial von Goldschmidt, H, Lokhorst, H M, Mai, E K, van der Holt, B, Blau, I W, Zweegman, S, Weisel, K C, Vellenga, E, Pfreundschuh, M, Kersten, M J, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, M S, Broijl, A, Lindemann, H W, Bos, G M J, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, R M, Bertsch, U, Hielscher, T, Jarari, Le, Salwender, H J, Sonneveld, P

Volltext

BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrog... von Turner, N.C., Alarcón, E., Armstrong, A.C., Philco, M., López Chuken, Y.A., Sablin, M.-P., Tamura, K., Gómez Villanueva, A., Pérez-Fidalgo, J.A., Cheung, S.Y.A., Corcoran, C., Cullberg, M., Davies, B.R., de Bruin, E.C., Foxley, A., Lindemann, J.P.O., Maudsley, R., Moschetta, M., Outhwaite, E., Pass, M., Rugman, P., Schiavon, G., Oliveira, M.

Volltext

Effect of Rashba and Dresselhaus spin–orbit coupling on supercurrent rectification and magnetochiral anisotropy of ballistic Josephson junctions von Baumgartner, C, Fuchs, L, Costa, A, Picó-Cortés, Jordi, Reinhardt, S, Gronin, S, Gardner, G C, Lindemann, T, Manfra, M J, Faria Junior, P E, Kochan, D, Fabian, J, Paradiso, N, Strunk, C

Volltext

Reconstructing A Grand Boulevard von KADERBEK, S. L, CASALINO, Denise, BLUMENSAADT, Irwin, LINDEMANN, Eric

Volltext

A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy re... von Hamilton, E., Oliveira, M., Turner, N., García-Corbacho, J., Hernando, C., Ciruelos, E.M., Kabos, P., Ruiz-Borrego, M., Armstrong, A., Patel, M.R., Vaklavas, C., Twelves, C., Boni, V., Incorvati, J., Brier, T., Gibbons, L., Klinowska, T., Lindemann, J.P.O., Morrow, C.J., Sykes, A., Baird, R.D.

Volltext

AKT Inhibition in Solid Tumors With AKT1 Mutations von Hyman, David M, Smyth, Lillian M, Donoghue, Mark T A, Westin, Shannon N, Bedard, Philippe L, Dean, Emma J, Bando, Hideaki, El-Khoueiry, Anthony B, Pérez-Fidalgo, José A, Mita, Alain, Schellens, Jan H M, Chang, Matthew T, Reichel, Jonathan B, Bouvier, Nancy, Selcuklu, S Duygu, Soumerai, Tara E, Torrisi, Jean, Erinjeri, Joseph P, Ambrose, Helen, Barrett, J Carl, Dougherty, Brian, Foxley, Andrew, Lindemann, Justin P O, McEwen, Robert, Pass, Martin, Schiavon, Gaia, Berger, Michael F, Chandarlapaty, Sarat, Solit, David B, Banerji, Udai, Baselga, José, Taylor, Barry S

Volltext

Transcriptional Profiles of a Foliar Fungal Endophyte ( Pestalotiopsis , Ascomycota) and Its Bacterial Symbiont ( Luteibacter , Gammaproteobacteria ) Reveal Sulfur Exchange and Gro... von Shaffer, Justin P, Carter, Morgan E, Spraker, Joseph E, Clark, Meara, Smith, Brian A, Hockett, Kevin L, Baltrus, David A, Arnold, A Elizabeth

Volltext

Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2 - and Non- BRCA1/2 -Mutant Cancers von Yap, Timothy A, Kristeleit, Rebecca, Michalarea, Vasiliki, Pettitt, Stephen J, Lim, Joline S J, Carreira, Suzanne, Roda, Desamparados, Miller, Rowan, Riisnaes, Ruth, Miranda, Susana, Figueiredo, Ines, Rodrigues, Daniel Nava, Ward, Sarah, Matthews, Ruth, Parmar, Mona, Turner, Alison, Tunariu, Nina, Chopra, Neha, Gevensleben, Heidrun, Turner, Nicholas C, Ruddle, Ruth, Raynaud, Florence I, Decordova, Shaun, Swales, Karen E, Finneran, Laura, Hall, Emma, Rugman, Paul, Lindemann, Justin P O, Foxley, Andrew, Lord, Christopher J, Banerji, Udai, Plummer, Ruth, Basu, Bristi, Lopez, Juanita S, Drew, Yvette, de Bono, Johann S

Volltext

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial von Pujade-Lauraine, E., Selle, F., Scambia, G., Asselain, B., Marmé, F., Lindemann, K., Colombo, N., Mądry, R., Glasspool, R., Vergote, I., Korach, J., Lheureux, S., Dubot, C., Oaknin, A., Zamagni, C., Heitz, F., Gladieff, L., Rubio-Pérez, M.J., Scollo, P., Blakeley, C., Shaw, B., Ray-Coquard, I., Redondo, A.

Volltext

In-plane quasi-single-domain BaTiO3 via interfacial symmetry engineering von Lee, J. W., Eom, K., Paudel, T. R., Wang, B., Lu, H., Huyan, H. X., Lindemann, S., Ryu, S., Lee, H., Kim, T. H., Yuan, Y., Zorn, J. A., Lei, S., Gao, W. P., Tybell, T., Gopalan, V., Pan, X. Q., Gruverman, A., Chen, L. Q., Tsymbal, E. Y., Eom, C. B.

Volltext

The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance von Lawson, Mandy, Cureton, Natalie, Ros, Susana, Cheraghchi-Bashi, Azadeh, Urosevic, Jelena, D'Arcy, Sophie, Delpuech, Oona, DuPont, Michelle, Fisher, David I, Gangl, Eric T, Lewis, Hilary, Trueman, Dawn, Wali, Neha, Williamson, Stuart C, Moss, Jennifer, Montaudon, Elodie, Derrien, Heloise, Marangoni, Elisabetta, Miragaia, Ricardo J, Gagrica, Sladjana, Morentin-Gutierrez, Pablo, Moss, Thomas A, Maglennon, Gareth, Sutton, Daniel, Polanski, Radoslaw, Rosen, Alan, Cairns, Jonathan, Zhang, Pei, Sánchez-Guixé, Mònica, Serra, Violeta, Critchlow, Susan E, Scott, James S, Lindemann, Justin P O, Barry, Simon T, Klinowska, Teresa, Morrow, Christopher J, Carnevalli, Larissa

Volltext

Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal von Lauber, Kirsten, Bohn, Erwin, Kröber, Stefan Martin, Xiao, Yi-jin, Blumenthal, Sibylle G., Lindemann, Ralph K., Marini, Patrizia, Wiedig, Carolin, Zobywalski, Anke, Baksh, Shairaz, Xu, Yan, Autenrieth, Ingo B., Schulze-Osthoff, Klaus, Belka, Claus, Stuhler, Gernot, Wesselborg, Sebastian

Volltext

Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER + Invasive Breast Cancer (STAKT) von Robertson, John F R, Coleman, Robert E, Cheung, Kwok-Leung, Evans, Abigail, Holcombe, Chris, Skene, Anthony, Rea, Daniel, Ahmed, Samreen, Jahan, Ali, Horgan, Kieran, Rauchhaus, Petra, Littleford, Roberta, Cheung, S Y Amy, Cullberg, Marie, de Bruin, Elza C, Koulai, Loumpiana, Lindemann, Justin P O, Pass, Martin, Rugman, Paul, Schiavon, Gaia, Deb, Rahul, Finlay, Pauline, Foxley, Andrew, Gee, Julia M W

Volltext

Dark matter results from 225 live days of XENON100 data von Aprile, E, Alfonsi, M, Arisaka, K, Arneodo, F, Balan, C, Baudis, L, Bauermeister, B, Behrens, A, Beltrame, P, Bokeloh, K, Brown, E, Bruno, G, Budnik, R, Cardoso, J M R, Chen, W-T, Choi, B, Cline, D, Colijn, A P, Contreras, H, Cussonneau, J P, Decowski, M P, Duchovni, E, Fattori, S, Ferella, A D, Fulgione, W, Gao, F, Garbini, M, Ghag, C, Giboni, K-L, Goetzke, L W, Grignon, C, Gross, E, Hampel, W, Kaether, F, Kish, A, Lamblin, J, Landsman, H, Lang, R F, Le Calloch, M, Levy, C, Lim, K E, Lin, Q, Lindemann, S, Lindner, M, Lopes, J A M, Lung, K, Marrodán Undagoitia, T, Massoli, F V, Melgarejo Fernandez, A J, Meng, Y, Molinario, A, Nativ, E, Ni, K, Oberlack, U, Orrigo, S E A, Pantic, E, Persiani, R, Plante, G, Priel, N, Rizzo, A, Rosendahl, S, dos Santos, J M F, Sartorelli, G, Schreiner, J, Schumann, M, Scotto Lavina, L, Scovell, P R, Selvi, M, Shagin, P, Simgen, H, Teymourian, A, Thers, D, Vitells, O, Wang, H, Weber, M, Weinheimer, C

Volltext

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final res... von Rödel, Claus, Prof, Graeven, Ullrich, MD, Fietkau, Rainer, Prof, Hohenberger, Werner, Prof, Hothorn, Torsten, Prof, Arnold, Dirk, Prof, Hofheinz, Ralf-Dieter, Prof, Ghadimi, Michael, Prof, Wolff, Hendrik A, MD, Lang-Welzenbach, Marga, MSc, Raab, Hans-Rudolf, Prof, Wittekind, Christian, Prof, Ströbel, Philipp, Prof, Staib, Ludger, Prof, Wilhelm, Martin, Prof, Grabenbauer, Gerhard G, Prof, Hoffmanns, Hans, MD, Lindemann, Fritz, MD, Schlenska-Lange, Anke, MD, Folprecht, Gunnar, Prof, Sauer, Rolf, Prof, Liersch, Torsten, Prof

Volltext

Automated approach for quantifying the repeated sit-to-stand using one body fixed sensor in young and older adults von Van Lummel, R.C, Ainsworth, E, Lindemann, U, Zijlstra, W, Chiari, L, Van Campen, P, Hausdorff, J.M

Volltext

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma von Lindemann, R.K, Newbold, A, Whitecross, K.F, Cluse, L.A, Frew, A.J, Ellis, L, Williams, S, Wiegmans, A.P, Dear, A.E, Scott, C.L, Pellegrini, M, Wei, A, Richon, V.M, Marks, Paul A, Lowe, S.W, Smyth, M.J, Johnstone, R.W

Volltext

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome von Berry-Kravis, Elizabeth M., Lindemann, Lothar, Jønch, Aia E., Apostol, George, Bear, Mark F., Carpenter, Randall L., Crawley, Jacqueline N., Curie, Aurore, Des Portes, Vincent, Hossain, Farah, Gasparini, Fabrizio, Gomez-Mancilla, Baltazar, Hessl, David, Loth, Eva, Scharf, Sebastian H., Wang, Paul P., Von Raison, Florian, Hagerman, Randi, Spooren, Will, Jacquemont, Sébastien

Volltext